Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000727852 | SCV000855315 | uncertain significance | not provided | 2018-07-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001393936 | SCV001595613 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2023-11-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002325444 | SCV002607254 | likely benign | Cardiovascular phenotype | 2019-07-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV000727852 | SCV003827276 | uncertain significance | not provided | 2019-04-18 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004540032 | SCV004784060 | likely benign | TTN-related disorder | 2019-08-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |